Great West Life Assurance CO Iveric Bio, Inc. Transaction History

Great West Life Assurance CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$18.67 - $24.56 $11,071 - $14,564	593 Added 12.41%	5,372 $131,000
Q3 2022 Nov 01, 2022	BUY	$9.4 - $18.59 $44,922 - $88,841	4,779 New	4,779 $85,000
Q1 2022 May 12, 2022	BUY	$12.15 - $16.83 $3,535 - $4,897	291 Added 9.89%	3,232 $58,000
Q3 2021 Nov 15, 2021	SELL	$7.07 - $17.5 $14,472 - $35,822	-2,047 Reduced 41.04%	2,941 $48,000
Q4 2020 Feb 16, 2021	BUY	$5.65 - $7.66 $28,182 - $38,208	4,988 New	4,988 $34,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.